VööSBaldewegSEKumarRSinghHMittalBRBomanjiJ.Perennial inconsistencies and lack of evidence-based recommendations in current guidelines addressing blood glucose level regulations for optimal 18F-fluorodeoxyglucose PET imaging: 25-year “silver jubilee” of an ongoing unsolved problem in nuclear medicine. Nucl Med Commun. 2024;45(11):897-900. doi:10.1097/MNM.0000000000001894
3.
SurasiDSBhambhavaniPBaldwinJA, et al. F-FDG PET and PET.CT patient preparation: a review of the literature. J Nucl Med Tech. 2014;42(1):5-13.
4.
ShankarLKHoffmanJMBacharachS, et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006;47(6):1059-1066.
5.
BoellaardRHerrmannKBarringtonSF, et al. [18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0. EANM J. 2025;1:100006. doi:10.1016/j.eanmj.2025.100006